Suppr超能文献

脂肪酸酰胺水解酶的α-酮杂环抑制剂:酰基侧链构象限制的探索

α-Ketoheterocycle inhibitors of fatty acid amide hydrolase: exploration of conformational constraints in the acyl side chain.

作者信息

Duncan Katharine K, Otrubova Katerina, Boger Dale L

机构信息

Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, United States.

Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, United States.

出版信息

Bioorg Med Chem. 2014 May 1;22(9):2763-70. doi: 10.1016/j.bmc.2014.03.013. Epub 2014 Mar 18.

Abstract

A series of α-ketooxazoles containing heteroatoms embedded within conformational constraints in the C2 acyl side chain of 2 (OL-135) were synthesized and evaluated as inhibitors of fatty acid amide hydrolase (FAAH). The studies reveal that the installation of a heteroatom (O) in the conformational constraint is achievable, although the potency of these novel derivatives is reduced slightly relative to 2 and the analogous 1,2,3,4-tetrahydronaphthalene series. Interestingly, both enantiomers (R and S) of the candidate inhibitors bearing a chiral center adjacent to the electrophilic carbonyl were found to effectively inhibit FAAH.

摘要

合成了一系列在2(OL-135)的C2酰基侧链的构象限制内嵌入杂原子的α-酮恶唑,并将其作为脂肪酸酰胺水解酶(FAAH)的抑制剂进行了评估。研究表明,在构象限制中引入杂原子(O)是可行的,尽管这些新型衍生物的效力相对于2和类似的1,2,3,4-四氢萘系列略有降低。有趣的是,发现带有与亲电羰基相邻的手性中心的候选抑制剂的两种对映体(R和S)均能有效抑制FAAH。

相似文献

1
α-Ketoheterocycle inhibitors of fatty acid amide hydrolase: exploration of conformational constraints in the acyl side chain.
Bioorg Med Chem. 2014 May 1;22(9):2763-70. doi: 10.1016/j.bmc.2014.03.013. Epub 2014 Mar 18.
5
Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase.
J Med Chem. 2008 Aug 14;51(15):4392-403. doi: 10.1021/jm800136b. Epub 2008 Jul 16.
6
Optimization of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.
J Med Chem. 2008 Feb 28;51(4):937-47. doi: 10.1021/jm701210y. Epub 2008 Feb 5.
7
Structure-activity relationships of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.
J Med Chem. 2007 Jul 12;50(14):3359-68. doi: 10.1021/jm061414r. Epub 2007 Jun 9.
8
Design, synthesis and evaluation of polar head group containing 2-keto-oxazole inhibitors of FAAH.
Bioorg Med Chem. 2012 Jan 15;20(2):1100-12. doi: 10.1016/j.bmc.2011.11.027. Epub 2011 Nov 28.
10
Rational design of fatty acid amide hydrolase inhibitors that act by covalently bonding to two active site residues.
J Am Chem Soc. 2013 Apr 24;135(16):6289-99. doi: 10.1021/ja4014997. Epub 2013 Apr 12.

引用本文的文献

1
The Difference a Single Atom Can Make: Synthesis and Design at the Chemistry-Biology Interface.
J Org Chem. 2017 Dec 1;82(23):11961-11980. doi: 10.1021/acs.joc.7b02088. Epub 2017 Oct 13.
2
Preclinical Characterization of the FAAH Inhibitor JNJ-42165279.
ACS Med Chem Lett. 2015 Nov 2;6(12):1204-8. doi: 10.1021/acsmedchemlett.5b00353. eCollection 2015 Dec 10.
3
Discovery libraries targeting the major enzyme classes: the serine hydrolases.
Bioorg Med Chem Lett. 2014 Aug 15;24(16):3807-13. doi: 10.1016/j.bmcl.2014.06.063. Epub 2014 Jun 27.

本文引用的文献

1
Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate.
ACS Med Chem Lett. 2012 Aug 22;3(10):823-7. doi: 10.1021/ml300186g. eCollection 2012 Oct 11.
2
Rational design of fatty acid amide hydrolase inhibitors that act by covalently bonding to two active site residues.
J Am Chem Soc. 2013 Apr 24;135(16):6289-99. doi: 10.1021/ja4014997. Epub 2013 Apr 12.
3
Synthesis, SAR study, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase (FAAH) inhibitors.
Bioorg Med Chem. 2013 Jan 1;21(1):28-41. doi: 10.1016/j.bmc.2012.11.006. Epub 2012 Nov 15.
4
α-Ketoheterocycle-based Inhibitors of Fatty Acid Amide Hydrolase (FAAH).
ACS Chem Neurosci. 2012 May 16;3(5):340-348. doi: 10.1021/cn2001206. Epub 2011 Dec 20.
6
The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH).
Bioorg Med Chem Lett. 2011 Aug 15;21(16):4674-85. doi: 10.1016/j.bmcl.2011.06.096. Epub 2011 Jun 28.
8
Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor.
ACS Med Chem Lett. 2011 Feb 10;2(2):91-96. doi: 10.1021/ml100190t.
10
Discovery and molecular basis of potent noncovalent inhibitors of fatty acid amide hydrolase (FAAH).
Proc Natl Acad Sci U S A. 2011 May 3;108(18):7379-84. doi: 10.1073/pnas.1016167108. Epub 2011 Apr 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验